Unicorn Biotechnologies

Unicorn Biotechnologies develops automated, benchtop biomanufacturing systems, such as their Emmet platform, designed to standardize and industrialize mammalian cell culture processes. By integrating physical AI, advanced hardware, and sensing technologies, the company aims to decouple biological research from manual labor. Their modular approach is specifically engineered to provide scalable solutions for diverse applications, including basic research, drug discovery, regenerative medicine, and cultivated meat production. By replacing manual liquid handling and monitoring with automated systems, they enable consistent, reproducible results for complex cell workflows, such as hiPSC expansion and differentiation.

This technology addresses significant industry barriers to scaling, such as process optimization challenges and high manufacturing costs, by allowing partners to move from lab-scale prototypes to commercial production without requiring re-engineering. By providing purpose-built equipment that operates in parallel, Unicorn helps biopharma and biotech firms reduce batch failures and labor requirements. Their solutions are used by R&D teams to accelerate the path to market for cell-based products, ensuring reliability and quality control through real-time onboard imaging and biochemical monitoring. The company operates as a collaborative partner, supporting organizations in automating laborious laboratory tasks to focus on scientific innovation.